Christopher Otero, APRN
Primary Care · Miami, FLNPI 1346928090
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,770 of the $6,390 with a category attached, or 74.6%. 26 manufacturers reported payments, led by Johnson & Johnson at 40.9% of the total. Among primary care clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 52 payments — averaging $122.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$3K
- AstraZeneca$692
- E.r. Squibb & Sons, L.L.C.$395
- AbbVie$245
- Jazz Pharmaceuticals Inc.$224
- Incyte Corporation$172
- plus $2K from 20 others
What the payments were for
- Consulting fees$1,62025%
- Food & beverage$4,77075%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 14 | $2,614 |
| AstraZeneca | 7 | $692 |
| E.r. Squibb & Sons, L.L.C. | 3 | $395 |
| AbbVie | 2 | $245 |
| Jazz Pharmaceuticals Inc. | 2 | $224 |
| Incyte Corporation | 3 | $172 |
| EMD Serono, Inc. | 1 | $146 |
| Genentech USA, Inc. | 1 | $143 |
| Dendreon Pharmaceuticals LLC | 1 | $135 |
| Novocure Inc. | 1 | $131 |
| Caris MPI, Inc. | 2 | $128 |
| Stemline Therapeutics Inc. | 1 | $125 |
| Sobi, Inc | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $125 |
| Beone Medicines USA, Inc. | 1 | $124 |
| Astellas Pharma US Inc | 1 | $118 |
| Amgen | 1 | $114 |
| Genentech, Inc. | 1 | $113 |
| Pfizer | 1 | $102 |
| Phathom Pharmaceuticals, Inc. | 1 | $102 |
| Avanos Medical | 1 | $101 |
| Janssen Scientific Affairs, LLC | 1 | $88 |
| Rigel Pharmaceuticals, Inc. | 1 | $57 |
| Novartis | 1 | $31 |
| Immunocore Limited | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,390 in reported general payments places this provider in the 95th percentile of 725 primary care providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other primary care in Miami
- Liliam PalaciosMiami$5K
- Paul ChanOrlando$447K
- Jenny WestPensacola$80K
- Railet RodriguezAltamonte Springs$14K
- Kevin HanawayFort Lauderdale$12K
- Kelly ChewningAlachua$11K
- Yolanda PalmeroSaint Cloud$11K
- Erica ClarkCitrus Springs$11K
- Michelle SelvaggiLakewood Ranch$10K
- Kristen DeasonTallahassee$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.